Immunizing the HIV-infected child

AIDS Patient Care and STDs

Volumn 11, Issue 3, 1997, Pages 149-160

  Rutstein, Richard M ^a   Starr, Stuart E ^b  

^a Divisions of General Pediatrics   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFUROXIME; CHICKENPOX VACCINE; COTRIMOXAZOLE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; INTERLEUKIN 2; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE; ZIDOVUDINE;

ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL INFECTION; CASE REPORT; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MALE; MEASLES; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS PNEUMONIA; POLIOMYELITIS; PRESCHOOL CHILD; VIRUS INFECTION;

EID: 0030928944     PISSN: 08935068     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.1997.11.149     Document Type: Article

References (70)

1. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. 7:13-20, 1995.
2. Borkowsky, W., Rigaud, M., Krasinski, K., et al. Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life. J Pediatr 120:371-375, 1992.
3. Kroon, F.P., vanDissel, J.T., deJong, J.C., vanFurth, R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 8:469-476, 1994.
4. Mongini, P.K.A., Stein, K.E., Paul, W.E. T cell regulation of IgG subclass antibody production in response to T-independent antigens. J Exp Med 153:1-12, 1981.
5. Baker, P.J. T cell regulation of the antibody response to bacterial polysaccharide antigens: An examination of some general characteristics and their implications. J Infect Dis 165(Suppl I):S44-S48, 1992.
6. Stein, K.E. Thymus-independent and thymus-depen dent responses to polysaccharide antigens. J Infect Dis 165(Suppl I):S49-52, 1992.
7. Borkowsky, W., Steele, C.J., Grubman, S., et al. Antibody responses to bacterial toxoids in children infected with human immunodeficiency virus. J Pediatr 110:563-566, 1988.
8. Al-Attar, I., Reisman, J., Muehlmann, M., McIntosh, K. Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J 14:149-151, 1995.
9. Stanley, S.K., Ostrowski, M.A., Justement, J.S., et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 334:1222-1230, 1996.
10. O'Brien, W.A., Grovit-Ferbas, K., Namazi, A., et al. Human immunodeficiency virus type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86:1082-1089, 1995.
11. Ramilo, O., Hicks, P.J., Borvak, J., et al. T cell activation and human immunodeficiency virus replication after influenza immunization of infected children. Pediatr Infect Dis J 15:197-203, 1996.
12. Cohen, S.E., Knorr, K.L., Gilligan, P.H., Smiler, M.L., Weber, D.J. Pertussis is rare in human immunodeficiency virus disease. Am Rev Respir Dis 147:411-413, 1993.
13. Adamson, P.C., Wu, T.C., Meade, B.D., Rubin, M., Manclark, C.R., Pizzo, P.A. Pertussis in a previously immunized child with human immunodeficiency virus infection. J Pediatr 115:589-592, 1989.
14. Krasinski, K., Borkowsky, W., Bonk, S., Lawrence, R., Chandwani, S. Bacterial infections in human immunodeficiency virus-infected children. Pediatr Infect Dis J 7:323-328, 1988.
15. Ryder, R.W., Oxtoby, M.J., Mvula, M., et al. Safety and immunogenicity of bacille Calmette-Guerin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. J Pediatr 122:697-702, 1993.
16. Barbi, M., Biffi, M.R., Binda, S., et al. Immunization in children with HIV seropositivity at birth: Antibody response to polio vaccine and tetanus toxoid. AIDS 6:1465-1469, 1992.
17. Steinhart, R., Reingold, A.L., Taylor, F., Anderson, G., Wenger, J.D. Invasive Haemophilus influenzae infections in men with HIV infection. JAMA 268:3350-3352, 1992.
18. Spector, S.A., Gelber, R.D., McGrath, N., et al. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. N Engl J Med 331:1181-1187, 1994.
19. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Study Group. Intravenous immunoglobulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. N Engl J Med 325:73-80, 1991.
20. Steinhoff, M.C., Auerbach, B.S., Nelson, K.E. Antibody responses to Haemophilus influenzae type b vaccines in men with human immunodeficiency virus infection. N Engl J Med 325:1837-1842, 1991.
21. Rutstein, R.M., Rudy, B.J., Cnaan, A. Response of human immunodeficiency virus-exposed and infected infants to Haemophilus influenzae type b conjugate vaccine. Arch Pediatr Adolesc Med. 150:838-841, 1996.
22. Kale, K.I., King, J.C., Fraley, J.J., Vink, P.E., Cimino, C.O., Paradiso, P.R. The immunogenicity of Haemophilus influenzae type b conjugate (HbOC) vaccine in human immunodeficiency virus-infected and uninfected infants. Pediatr Infect Dis J 14:350-353, 1995.
23. Gibb, D., Spoulou, V., Giacomelli, A., et al. Antibody responses to Haemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection. Pediatr Infect Dis J 14:129-135, 1995.
24. Peters, V.B., Sood, S.K. Immunity to Haemophilus influenzae type b polysaccharide capsule in children with human immunodeficiency virus infection immunized with a single dose of Haemophilus vaccine. J Pediatr 125:74-77, 1994.
25. Gibb, D., Giacomelli, A., Masters, J., et al. Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J 15:1097-1101, 1996.
26. Keet, I.P.M., vanDoornum, G., Safary, A., Coutinho, R.A. Insufficient response to hepatitis B vaccination in HIV-positive homosexual men (Letter). AIDS 6:509-510, 1992.
27. Loke, R.H.T., Murray-Lyon, I.M., Coleman, J.C., Evans, B.A., Zuckerman, A.J. Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: An indicator of poor prognosis. J Med Virol 31:109-111, 1990.
28. Bruguerra, M., Cremades, M., Salinas, R., Costa, J., Grau, M., Sans, J. Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. J Clin Gastroenterol 14:27-30, 1992.
29. Greenberg, D.P. Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies. Pediatr Infect Dis J. 12:438-445, 1993.
30. Rutstein, R.M., Rudy, B., Codispoti, C., Watson, B. Response to hepatitis B immunization by infants exposed to HIV. AIDS 8:1281-1284, 1994.
31. Zuin, G., Principi, N., Tornaghi, R., et al. Impaired response to hepatitis B vaccine in HIV-infected children. Vaccine 10:857-860, 1992.
32. Zuccotti, G.V., Riva, E., Flumine, P., et al. Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus. J Pediatr 125:70-72, 1994.
33. Diamant, E.P., Schechter, C., Hodes, D.S., Peters, V.B. Immunogenicity of hepatitis B vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J 12:877-878, 1993.
34. Choudhury, S.A., Peters, V.B. Responses to hepatitis B vaccine boosters in human immunodeficiency virus-infected children. Pediatr Infect Dis J 14:65-67, 1995.
35. Vernon, A., Okwo, B., Lubamba, N., Miaka, M.B., Kashamuka, M. Paralytic poliomyelitis and HIV infection in Kinshasa, Zaire. Int Conf AIDS 6:355 (abstract No. 2003), 1990.
36. Vardinon, N., Handsher, R., Burke, M., Zacut, V., Yust, I. Poliovirus vaccination responses in HIV-infected patients: Correlation with T4 cell counts. J Infect Dis 162:238-241, 1990.
37. Ion-Nedelcu, N., Dobrescu, A., Strebel, P.M., Sutter, R.W. Vaccine-associated paralytic poliomyelitis and HIV infection (Letter). Lancet 343:51-52, 1994.
38. McLaughlin, M., Thomas, P., Onorato, I., et al. Live virus vaccines in human immunodeficiency virus-infected children: A retrospective survey. Pediatrics 82:229, 1988.
39. Kaplan, L.J., Daum, R.S., Smaron, M., McCarthy, C.A. Severe measles in immunocompromised patients. JAMA 267:1237-1241, 1992.
40. Vigliano, P., Boffi, P., Giordana, M.T., et al. Subacute measles encephalitis in a boy with perinatal HIV-1 infection. Dev Med Child Neurol 37:1117-1119, 1995.
41. Palumbo, P., Hoyt, L., DeMasio, K., et al. Population-based study of measles and measles immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J 11:1008-1014, 1992.
42. Measles in HIV-infected children. MMWR 37:183-185, 1988.
43. Krasinski, K., Borkowsky, W. Measles and measles immunity in children infected with human immunodeficiency virus. JAMA 261:2512-2516, 1989.
44. Brena, A.E., Cooper, E.R., Cabral, H.J., Pelton, S.I. Antibody response to measles and rubella vaccine by children with HIV infection. J Acquir Immune Defic Syndr 6:1125-1129, 1993.
45. Rudy, B., Rutstein, R.M., Pinto-Martin, J. Response to measles immunization in children infected with human immunodeficiency virus. J Pediatr 125:72-74, 1994.
46. Immunization of children infected with human immunodeficiency virus - Supplementary ACIP statement. MMWR 37:181-183, 1988.
47. Angel, J.B., Udem, S.A., Syndman, D.R., et al. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV Infection. MMWR 45:603-606, 1993.
48. Jura, E., Chadwick, E.G., Josephs, S.H., et al. Varicellazoster virus infections in children infected with human immunodeficiency virus. Pediatr Infect Dis J 8:586-590, 1989.
49. Kelley, R., Mancao, M., Lee, F., et al. Varicella in children with perinatally acquired human immunodeficiency virus infection. J Pediatr 124:271-273, 1994.
50. Silliman, C.C., Tedder, D., Ogle, J.W., et al. Unsuspected varicella-zoster virus encephalitis in a child with acquired immunodeficiency syndrome. J Pediatr 123:418-422, 1993.
51. Huang, Y.C., Lin, T.Y., Chiu, C.H. Acyclovir prophylaxis of varicella after household exposure. Pediatr Infect Dis J 14:152-154, 1995.
52. Harper, M.C., Reddington, M., Cohen, C., et al. Serious pneumococcal infections (SPI) in HIV-infected children. Abstr Intersci Conf Antimicrob Agents Chemother Oct 4-7, 1994, p 36.
53. Klein, R.S., Selwyn, P.A., Maude, D., Pollard, C., Freeman, K., Schiffman, G. Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with human immunodeficiency virus. J Infect Dis 160:826-831, 1989.
54. Vandenbruaene, M., Colebunders, R., Mascart-Lemone, F., et al. Equal IgG antibody response to pneumococcal vaccination in all stages of human immunodeficiency virus disease. J Infect Dis 172:551-553, 1995.
55. Rodriguez-Barradas, M.C., Groover, J.E., Lacke, C.E., et al. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: Persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J Infect Dis 173:1347-1353, 1996.
56. Bjornson, A.B., Falletta, J.M., Verter, J.L., et al. Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: Effects of continued penicillin prophylaxis. J Pediatr 129:828-835, 1996.
57. Arpadi, S.M., Back, S., O'Brien, J., Janoff, E.N. Antibodies to pneumococcal capsular polysaccharides in children with human immunodeficiency virus infection given polyvalent pneumococcal vaccine. J Pediatr 125:77-79, 1994.
58. Peters, V.B., Diamant, E.P., Hodes, D.S., Cimino, C.O. Impaired immunity to pneumococcal polysaccharide antigens in children with human immunodeficiency virus infection immunized with pneumococcal vaccine. Pediatr Infect Dis J 13:933-934, 1994.
59. King, J.C., Vink, P.E., Farley, J.J., et al. Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children. Pediatr Infect Dis J 15:192-196, 1996.
60. Mayer, H.B., Rose, D.N., Cohen, S., Gurtman, A.C., Cheung, T.W., Szabo, S. The effect of Pneumocystis carinii pneumonia prophylaxis regimens on the incidence of bacterial infections in HIV-infected patients. AIDS 7:1687-1689, 1993.
61. Peters, V.B., Hyatt, A.C., Schechter, C., Diamant, E.P., Hodes, D.S. Evaluation of prophylaxis against invasive pneumococcal infections in human immunodefi ciency virus-infected children. Pediatr Infect Dis J 13:667-669, 1994.
62. Morris, C.F., Mahannah, S.R., Smith-Whitley, K., Ohene-Frempong, K., McGowan, K.L. Pneumococcal colonization in children with sickle cell disease. J Pediatr 129:821-627, 1996.
63. Miotti, P.C., Nelson, K.E., Dallabetta, G.A., et al. The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA 262:779-783, 1989.
64. Rose, D.N., Schiechter, C.B., Sacks, H.S. Influenza and pneumococcal vaccination of HIV-infected patients: A policy analysis. Am J Med 94:160-168, 1993.
65. Chadwick, E.G., Chang, G., Decker, M.D., et al. Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J 13:206-211, 1994.
66. Nelson, K.E., Clements, M.L., Miotti, P., Cohn, S., Polk, B.F. The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. Ann Intern Med 109:383-388, 1988.
67. Glaser, J.B., Volpe, S., Aguirre, A., Simpkins, H., Schiffman, G. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex. J Infect Dis 164:761-764, 1991.
68. Kelleher, A.D., Carr, A., Zaunders, J., Cooper, D.A. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, Ritonavir. J Infect Dis 173:321-329, 1996.
69. Kovacs, J.A., Vogel, S., Albert, J., et al. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med 33:1350-1356, 1996.
70. Edge, M.D., Rimland, D. Community-acquired bacteremia in HIV-positive patients: Protective benefit of co-trimoxazole. AIDS 10:1635-1639, 1996.